Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

The Ribavirin Pregnancy Registry (RPR)

This study is currently recruiting participants. (see Contacts and Locations)
Verified January 2017 by INC Research
Aurobindo Pharma
Genentech, Inc.
Merck Sharp & Dohme Corp.
Teva Pharmaceuticals USA
Zydus Pharmaceuticals USA, Inc.
Kadmon Pharmaceuticals
Information provided by (Responsible Party):
INC Research Identifier:
First received: June 16, 2005
Last updated: January 23, 2017
Last verified: January 2017
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2025
  Estimated Primary Completion Date: December 2024 (Final data collection date for primary outcome measure)